Ignite Creation Date:
2024-05-05 @ 10:59 PM
Last Modification Date:
2024-10-26 @ 10:26 AM
Study NCT ID:
NCT01220128
Status:
TERMINATED
Last Update Posted:
2021-05-25
First Post:
2010-10-07
Brief Title:
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline